Rhumbline Advisers Nuvectis Pharma, Inc. Transaction History

Rhumbline Advisers

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$5.98 - $8.25 $33,673 - $46,455	-5,631 Reduced 75.06%	1,871 $11,000
Q1 2024 May 09, 2024	BUY	$6.69 - $11.0 $1,532 - $2,519	229 Added 3.15%	7,502 $61,000
Q3 2023 Nov 09, 2023	BUY	$12.89 - $16.29 $6,380 - $8,063	495 Added 7.3%	7,273 $93,000
Q2 2023 Aug 08, 2023	BUY	$12.62 - $18.4 $85,538 - $124,715	6,778 New	6,778 $108,000

1.65M

Ticker NVCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,642,500
Market Cap $68.8M
Description
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.